Sage Journals: Discover world-class research

Retricted access

Review article

First published 2018-9

A review of CD19-targeted immunotherapies for relapsed or refractory acute lymphoblastic leukemia

Ryan K DasGupta, Bernard L Marini, Joslyn Rudoni [...]

Journal of Oncology Pharmacy Practice

Free access

Review article

First published 2016-6

The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia

Jonathan E. Benjamin, Anthony S. Stein

Therapeutic Advances in Hematology

Retricted access

Case report

First published 2018-1

Successful reintroduction of blinatumomab in a patient with relapsed/refractory acute lymphoblastic leukemia following grade 4 cytokine release syndrome

Bernard L Marini, Yihan Sun, Patrick W Burke [...]

Journal of Oncology Pharmacy Practice

Open access

Research article

First published 2023

Superior survival outcome of blinatumomab compared with conventional chemotherapy for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia: a propensity score–matched cohort analysis

Jae-Ho Yoon, Daehun Kwag, Jong-Hyuk Lee [...]

Therapeutic Advances in Hematology

Retricted access

Case report

First published 2025-12

Combined CAR-T/HSCT approach in a patient with refractory acute lymphoblastic leukemia and cystic fibrosis

Benedetta E Di Majo, Francesca Vendemini, Sonia Bonanomi [...]

Tumori Journal

Free access

Review article

First published 2014-2

Liposomal vincristine for relapsed or refractory Ph-negative acute lymphoblastic leukemia: a review of literature

Priyanka Pathak, Rosemary Hess, Mark A. Weiss

Therapeutic Advances in Hematology

Retricted access

Case report

First published 2022-7

Cytogenetic guided therapy using blinatumomab and inotuzumab ozogamicin in a patient with relapse/refractory acute lymphoblastic leukemia

Zahava Ohana, Samantha Serraes, Christopher Elder [...]

Journal of Oncology Pharmacy Practice

Free access

Review article

First published 2015-10

The clinical potential of inotuzumab ozogamicin in relapsed and refractory acute lymphocytic leukemia

Musa Yilmaz, Samantha Richard, Elias Jabbour

Therapeutic Advances in Hematology

Open access

Review article

First published 2023

Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab

Hagop M. Kantarjian, Aaron C. Logan, Faraz Zaman [...]

Therapeutic Advances in Hematology

Retricted access

Research article

First published 2018-10

High-Dose Vincristine Sulfate Liposome Injection,for Advanced,Relapsed,or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in an Adolescent and Young Adult Subgroup of a Phase 2 Clinical Trial

Gary J. Schiller, Lloyd E. Damon, Steven E. Coutre [...]

Journal of Adolescent and Young Adult Oncology

Search results